Dr Iyabo Tinubu-Karch, CEO, Sidra Medicine is no stranger to the world of decision-making while being a medical professional. In a candid conversation, Dr Tinubu-Karch talks about the transition to a CEO and the values it demanded inculcated in her, apart from the role technology plays in diagnostics today.
“Technology is the cornerstone of our ability to expand and enhance our clinical services, ensuring we provide exceptional care for women and children.“
“Stepping from the boardroom into the CEO role has been an incredible journey. While my board role focused on strategic oversight and high-level decisions, my current position has immersed me in the daily operations of Sidra Medicine. This deeper involvement has provided invaluable insights into the challenges and opportunities we face, which allows me to ensure our teams have the necessary resources to excel in patient care, research, and education,” says Dr Iyabo Tinubu-Karch, CEO, Sidra Medicine.
One of the biggest shifts for Dr Tinubu-Karch has been getting to know the people on a deeper level. Witnessing their commitment firsthand is truly inspiring and reinforces her responsibility to foster a collaborative and inclusive work environment, according to Dr Tinubu-Karch, who actively seeks input from diverse perspectives within the organisation, believing as she does that this collective wisdom leads to more informed and effective decision-making.
“Healthcare is a dynamic field. As CEO, I need to make sure that we as an institution are agile and adaptable. This means being committed to nurturing a culture of innovation and continuous improvement. By embracing change and fostering a growth mindset, we can ensure that Sidra Medicine remains at the forefront of women’s and children’s healthcare,” informs Dr Tinubu-Karch.
On the role that technology plays in advancing clinical care at Sidra Medicine, Dr Tinubu-Karch is forceful about Sidra Medicine’s commitment to embracing the latest technological advancements based as it is on the belief that advanced technology is essential for the institution to remain a leader in patient care, adding, “Technology is the cornerstone of our ability to expand and enhance our clinical services, ensuring we provide exceptional care for women and children.”
Dr Tinubu-Karch adds that Sidra Medicine has become a regional pioneer in gene therapy, harnessing the power of technology to revolutionise treatment options for genetic diseases. Our administration of Elevidys for Duchenne Muscular Dystrophy (DMD) and our unique position as the sole provider of gene therapy for Spinal Muscular Atrophy (SMA) in Qatar exemplify this commitment.
How has Dr Tinubu-Karch’s background in geriatric medicine shaped your approach to healthcare leadership?
Dr Tinubu-Karch informs that her background in geriatric medicine has profoundly influenced her approach to healthcare leadership. She details, “In geriatrics, you learn to consider not only the immediate medical issues but also the broader context of a patient’s life – how their environment, family support, mental well-being, and social circumstances all influence their health. This perspective is essential for providing compassionate, effective care, and it informs how I lead a multidisciplinary team, with a collaborative agenda at a healthcare institution like Sidra Medicine.” Geriatric medicine, Dr Tinubu-Karch adds, emphasises long-term health and quality of life, not just treating immediate symptoms. “This philosophy is central to Sidra Medicine’s approach. We’re not only focused on acute interventions but also on providing sustainable, comprehensive care that supports the overall well-being of our patients and their families. My background has instilled in me a deep respect for the continuity of care, which we strive to deliver at every stage of a patient’s journey here,” says Dr Tinubu-Karch.
Innovations in healthcare
At Sidra Medicine, innovation is at the heart of our mission to provide exceptional care for children and women. Dr Tinubu-Karch talks about several ways in which Sidra Medicine is constantly striving to achieve new milestones and push the boundaries of healthcare through several key initiatives.
One key area is our Clinical Trials Program, which focuses on trials directly benefiting children in the Arab region, informs Dr Tinubu-Karch. The trials could offer children the chance to receive beneficial treatment whether it is a new drug, therapy, device or procedure before it becomes widely available, she says, adding, “Our programme addresses the historical lack of research for the Arab population, enabling us to develop personalised and effective treatments.” In tandem, Sidra Medicine has also established the first pediatric hematopoietic stem cell transplant (HSCT) programme in Qatar, in partnership with the Children’s Hospital of Philadelphia. “Additionally, our precision medicine initiatives leverage genomic data to personalise care plans, using advanced technologies such as Whole Genome Sequencing (WGS) to identify disease-linked genetic variations and Zebrafish Functional Genomics Facility for rapid gene mutation identification. We are strategically integrating Artificial Intelligence (AI) into our operations to empower our patients and optimise our workflow.
Global healthcare trends in women’s and children’s health
- Precision Medicine: The personalization of healthcare is one of the most significant advancements in modern medicine. We are deeply committed to representing the unique needs of Middle Eastern populations.
- Health Literacy and Patient Empowerment: The shift towards patient-centered care models is transforming the healthcare landscape. Our healthcare leaders are empowering patients to actively participate in their healthcare decisions by promoting health literacy.
- Mental Health: There is a growing recognition of the importance of mental health, particularly among women and adolescents. Destigmatizing mental health issues and integrating mental health services into our care are key steps in ensuring a holistic approach to health.
